Arcadia Biosciences, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | 89.6% | -389.3% | -414.1% |
| Jun 2017 | 88.3% | -377.1% | -404.2% |
| Sep 2017 | 93.2% | -613.8% | -768.3% |
| Dec 2017 | 98.5% | -210.1% | -207.3% |
| Mar 2018 | 83.2% | -1,793.9% | -4,960.3% |
| Jun 2018 | — | -1,050.0% | -1,529.6% |
| Sep 2018 | — | -1,107.8% | 1,202.7% |
| Dec 2018 | — | -980.6% | -145.5% |
| Mar 2019 | — | -2,669.6% | -7,982.3% |
| Jun 2019 | — | -2,454.2% | 2,087.2% |
| Sep 2019 | — | -1,579.8% | -3,619.1% |
| Dec 2019 | — | -958.7% | -1,500.7% |
| Mar 2020 | — | -1,873.8% | 817.2% |
| Jun 2020 | — | -2,447.0% | -3,448.0% |
| Sep 2020 | — | -2,414.3% | -2,035.4% |
| Dec 2020 | — | 104.8% | 124.8% |
| Mar 2021 | -3.4% | -643.2% | 248.6% |
| Jun 2021 | -13.0% | -546.8% | -374.4% |
| Sep 2021 | -5.7% | -366.7% | -91.5% |
| Dec 2021 | -72.9% | -635.9% | -427.5% |
| Mar 2022 | -7.4% | -143.6% | -139.4% |
| Jun 2022 | 10.7% | -98.1% | -97.9% |
| Sep 2022 | 28.2% | -254.2% | -182.6% |
| Dec 2022 | -57.1% | 130.9% | 345.0% |
| Mar 2023 | 44.2% | -313.9% | -761.7% |
| Jun 2023 | 49.9% | -112.1% | 63.5% |
| Sep 2023 | 37.0% | -107.6% | -197.8% |
| Dec 2023 | 97.1% | 98.2% | -455.0% |
| Mar 2024 | 52.3% | -160.9% | -245.5% |
| Jun 2024 | 51.5% | 151.6% | 81.2% |
| Sep 2024 | 32.9% | -114.5% | -104.9% |
| Dec 2024 | 31.9% | -187.7% | -334.5% |
| Mar 2025 | 43.2% | 44.2% | 216.6% |
| Jun 2025 | 43.4% | -34.4% | -306.4% |
| Sep 2025 | 32.1% | -88.5% | 65.7% |
| Dec 2025 | 21.4% | -152.8% | -148.3% |
| Mar 2026 | 36.4% | -70.8% | -398.6% |
| Jun 2026 | 43.7% | -34.4% | -434.2% |